Latest Investor Relations News

SomnoMed Limited prepares to unveil its H1FY25 financial results on February 28, 2025, accompanied by a live investor presentation and Q&A session. The company remains a global leader in sleep apnea treatment solutions.

Cyprium Metals has completed the second tranche of its placement, raising A$13.5 million through issuing over 483 million shares and accompanying options, positioning the company to accelerate development at its flagship Nifty Copper Mine.

AKORA Resources has raised $1.293 million through a strategic share placement involving its first institutional investor and full board participation, aiming to advance logistics and investor discussions for its Bekisopa iron ore project.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

Taiton Resources has acquired key land at its Kingsgate Project and reported exceptionally pure quartz samples, underpinning its strategic focus on high-value mineral exploration in New South Wales.

IVE Group Limited has scheduled its half-year financial results release for February 24, 2025, alongside a notable governance change with Paul Selig moving from Executive to Non-Executive Director.

Li-S Energy has set a new benchmark in lithium-sulfur battery technology, achieving a record 456Wh/kg energy density and successfully powering its first UAV test flights, signaling strong momentum in sustainable battery innovation.

Norwood Systems has launched its CogVoice OpenSpan platform on Microsoft Azure, deepening global CSP engagements and securing additional funding to support its AI-driven voice technology expansion.

Dragon Mountain Gold Limited reports promising drilling results at its Avalon Project and prepares for further exploration at Cawse, supported by a successful $670,000 capital raise and strategic board appointment.

Tigers Realm Coal is finalising the sale of its Russian subsidiaries for US$49 million, pending crucial Presidential approval, while navigating recent leadership shifts.

Echo IQ Limited has secured FDA clearance for its EchoSolv AS technology and appointed a US-based CEO, marking a pivotal shift towards commercialisation in the American healthcare market.

Identitii reports solid quarterly progress highlighted by a strategic new director appointment, US market expansion, and a successful $1.8 million capital raise, underpinning its path toward profitability.